SP-0317: Fear of recurrence and disease progression in long-term cancer survivors  by Koch, L.
3rd ESTRO Forum 2015                                                                                                                                         S159 
 
Symposium with Proffered Papers: Psycho-social aspects of 
radiation therapy: Late side effects and survivorship  
 
 
SP-0317   
Fear of recurrence and disease progression in long-term 
cancer survivors 
L. Koch1 
1German Cancer Research Center, Clinical Epidemiology and 
Aging Research, Heidelberg, Germany  
 
Purpose/Objective: Fear of recurrence (FoR), generally 
defined as the fear of the disease recurring or progressing in 
the same organ or a different area of the body, is among the 
main and most important concerns for cancer survivors. As 
opposed to anxiety disorders, FoR is not necessarily an 
irrational fear, but a reaction to a real threat. Specifically 
high levels of FoR can be dysfunctional, overwhelming 
survivors and negatively affecting their quality of life. 
Younger age and a lower educational level were repeatedly 
shown to be associated with higher FoR, whereas disease and 
treatment characteristics like stage or therapy were 
generally not found to be associated.  
Materials/Methods: Results are based on analyses of cross-
sectional data of long-term cancer survivors (>5 years post-
diagnosis) of the population-based CAESAR-study (Cancer 
Survivorship – a multi-regional population-based study). 
Survivors were recruited by six German population-based 
cancer registries. Overall, 6057 long-term breast-, colorectal, 
and prostate cancer survivors were included in the analyses. 
FoR was assessed using the short form of the Fear of 
Progression Questionnaire (FoP-Q-SF). The associations of 
age, sex, cancer type, stage, recurrence/metastases, time 
since diagnosis, education, and social support with 
moderate/high FoR were identified via multiple logistic 
regression analyses.  
Results: Even though the majority of long term cancer 
survivors reported to experience FoR in low intensity (87%), a 
significant percentage reported moderate (9%) or high (4%) 
FoR. Female survivors (Odds Ratio [OR] 3.49; p=0.002), 
survivors below 55 or 55 to 60 years of age (OR 3.32 and 2.70; 
p<0.0001 and p=0.0002), with an education of less than 10 
years (OR 2.28; p= <0.0001), having suffered from a 
recurrence or metastases (2.48; p= <0.0001), or those being 
socially isolated (OR 2.78; p<0.0001) were at a greater risk to 
experience moderate/high levels of FoR. Cancer type and 
time since diagnosis did not reach statistical significance.  
Conclusion: Even years after the initial diagnosis and 
completion of therapy, a substantial proportion of cancer 
survivors experience FoR at possibly debilitating levels. Our 
results indicate a potential vulnerability for women to 
experience FoR in high severity. Also younger and socially 
isolated survivors were at greater risk to suffer from high 
levels of FoR and should thus be monitored for high levels of 
FoR and should be offered the support needed to manage 
their fears. 
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With medical advances in treatment, childhood cancer has 
become more akin to a chronic illness than a terminal 
disease. With advanced treatments and increased survival 
rates there is an emerging population of young adult survivors 
who may be faced with unique developmental and 
psychosocial challenges.  
There are contradictory findings from the psychological 
evidence base as to whether survivors are at increased risk of 
psychological late effects as a result of their illness and/or 
treatment, with some studies reporting higher levels of 
psychological distress (e.g., Patenaude & Kupst, 2005) and 
others generally reporting good adjustment (Sundberg et al. 
2009). 
Irrespective of whether long-term survivors of childhood 
cancer are at an increased psychological risk, conclusive 
evidence appears to support the view that many experience 
problems in other domains such as education and career 
progression that greatly affect their quality of life.  
On entering adolescence, survivors may experience a greater 
appreciation of their previous illness and its life-threatening 
nature. This can lead to fears of relapse and elevated levels 
of post-traumatic stress (Taylor et al. 2012). Emerging 
physical late effects such as compromised fertility may 
threaten the survivor’s ability to negotiate life goals such as 
forming intimate relationships or parenting (Pivetta et al. 
2011). Outcome studies have found greater percentage of 
long-term survivors in lower skill jobs than siblings (Kirchhoff 
et al. 2011) and unemployed (Kirchhoff et al. 2010). 
Langeveld et al. (2003) found percentages of those 
employed, married or parents were less than those in a 
comparison group of participants with no history of cancer.  
Managing the combined demands of both adolescence/young 
adulthood and survivorship may mean that survivors may be 
more in need of psychological support during the post-
treatment phase of their illness than during treatment. This 
presentation will explore these psychological and 
developmental challenges for young survivors post-treatment 
while highlighting the clinical implications for the 
professionals who treat them. 
    
SP-0319   
Psycho-sexual support for pelvic radiation therapy for 
women and the impact on Quality of Life  
H. Toelen1 
1University Hospital Leuven, Gynecology, Leuven, Belgium  
 
Literature and clinical practice both indicate that women 
who are irradiated for cancer in the pelvic area do 
experience severe  long term sexual side effects from the 
treatment. Amongst others, they suffer from diminished 
desire, atrophy, difficulty in reaching an orgasm, changed 
sensitivity of the vaginal walls, premature menopause, grief 
over loss of fertility, loss of vaginal elasticity, shortened and 
more narrow vagina, stenosis and dyspareunia. 
While the side-effects such as premature menopause and loss 
of fertility are irreversible, the shortening and narrowing of 
the vaginal walls - and thus indirectly pain during a 
gynecological examination or during sexual activity - can be 
partially prevented. To prevent the shortening and narrowing 
of the vagina,  women have to dilate the vagina three times a 
week for ten minutes. This hands on treatment is a helpful 
mean to keep both  gynecological examination and sexual 
intercourse possible. It has been suggested that regular 
dilating is necessary up till two years after treatment.  
A lot of women, however, report that this preventive “work” 
is psychologically burdensome. The necessity to dilate the 
vagina with an object, for example a dilator, is experienced 
as being embarrassing and artificial. Moreover, the 
knowledge that the vagina is irradiated and sensitive makes 
women fearful to start dilating based on the expectation of 
pain. However, the alternative of natural dilating by having 
intercourse is an idea that is often felt as coming too soon 
